Karen H. Antman

An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas.

Karen H. Antman, John Crowley, S P Balcerzak et al. · Journal of Clinical Oncology · 1993 · 481 citations

Medicine, Oncology, Pharmacology +17

Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk.

T. Frank, Susan Manley, O. I. Olopade et al. · Journal of Clinical Oncology · 1998 · 462 citations

Medicine, Genetics, Oncology +17

Serotherapy of a patient with a monoclonal antibody directed against a human lymphoma-associated antigen.

Lee M. Nadler, Philip Stashenko, Russell Hardy et al. · PubMed · 1980 · 416 citations

Life Sciences, Immunology, Oncology +17

A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy.

Karen H. Antman, Lois Ayash, Anthony Elias et al. · Journal of Clinical Oncology · 1992 · 374 citations

Medicine, Oncology, Pharmacotherapy +17

Introduction: The History of Arsenic Trioxide in Cancer Therapy

Karen H. Antman · The Oncologist · 2001 · 360 citations · Full text

Medicine, Hematology, Oncology +15